✦ LIBER ✦

P21. Pharmacoeconomic analysis in the formulary decision-making process

✍ Scribed by P. Duong; N. Johnson

Book ID: 117322004
Publisher: Elsevier Science
Year: 1996
Tongue: English
Weight: 76 KB
Volume: 18
Category: Article
ISSN: 0149-2918
DOI: 10.1016/s0149-2918(96)80161-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PUP2: PHARMACOECONOMIC INFORMATION IN FO

PUP2: PHARMACOECONOMIC INFORMATION IN FORMULARY DECISION-MAKING IN THE UNITED STATES

✍ C Evans; E Dukes; L Bailey; B Crawford 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 54 KB

The role of pharmacoeconomics in formula

The role of pharmacoeconomics in formulary decision making in different hospitals in Riyadh, Saudi Arabia

✍ Mohammed S. Alsultan 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 358 KB

The use of pharmacoeconomic evidence to

The use of pharmacoeconomic evidence to support formulary decision making in Saudi Arabia: Methodological recommendations

✍ Sinaa A. AL Aqeel; Mohammed Al-Sultan 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 465 KB

PCASE7 INCLUDING A PHARMACOECONOMIC MODE

PCASE7 INCLUDING A PHARMACOECONOMIC MODEL IN THE FORMULARY REVIEW PROCESS OF NEW

✍ J Grossomanides; C Possidente 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

Cost-effectiveness analysis and formular

Cost-effectiveness analysis and formulary decision making in England: Findings from research

✍ Iestyn P. Williams; Stirling Bryan 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 205 KB

Design in the decision-making process

✍ Ernest R. Alexander 📂 Article 📅 1982 🏛 Springer US 🌐 English ⚖ 882 KB

The design of alternative courses of action is an essential part of decision-making, but one which has been neglected in theory and practice. A pilot study of alternatives' design in organizations suggests that already in the design stage choice focuses on a few alternatives, highlighting the import